`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________________________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________________________
`
`
`RIGEL PHARMACEUTICALS, INC.,
`
`Petitioner,
`
`v.
`
`SERVIER PHARMACEUTICALS LLC
`
`Patent Owner.
`
`____________________________
`
`Case IPR2022-01423
`U.S. Patent No. 10,610,125
`
`
`JOINT REQUEST TO TREAT EXHIBITS 1059 AND 1060
`AS BUSINESS CONFIDENTIAL INFORMATION
`
`
`
`
`
`
`
`
`
`
`The Parties have jointly filed a motion to terminate this proceeding pursuant
`
`to a settlement agreement between the Parties. Pursuant to the Board’s request as
`
`set forth in its email of December 19, 2022 and in accordance with 35 U.S.C.
`
`§317(b), the Parties have filed the settlement agreements as Exhibits 1059 and
`
`1060. The settlement agreements provide that the terms of the agreement are to be
`
`maintained as confidential by the Parties and, subject to certain exceptions, may
`
`not be disclosed to any third parties without the express written consent of the non-
`
`disclosing party.
`
`
`
`The Board has granted the Parties leave to file this motion to treat the
`
`settlement agreements as business confidential information. The Parties therefore
`
`jointly move pursuant to 37 C.F.R. § 42.74(c) that the settlement agreements,
`
`submitted as Exhibits 1059 and 1060, be treated as business confidential
`
`information and be kept separate from the files of the patent at issue in this
`
`proceeding.
`
`
`
`
`
`
`
`1
`
`
`
`
`
`
`Date: December 27, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`By: /James L. Lovsin/
` James L. Lovsin, Reg. No. 69,550
`
`lovsin@mbhb.com
` MCDONNELL BOEHNEN
` HULBERT & BERGHOFF LLP
` 300 S. Wacker Drive
` Chicago, IL 60606
` 312-913-0001
`
`
` Counsel for Petitioner
` Rigel Pharmaceuticals, Inc.
`
`
`
`
` /William M. Fink/
`
` William M. Fink, Reg. No. 72,332
`
`
`tfink@omm.com
`
`
` O’MELVENY & MYERS LLP
`
`
` 1625 I Street NW
` Washington D.C. 20006
`
` (202) 383-5300
`
`
`
`
` Counsel for Patent Owner
` Servier Pharmaceuticals LLC
`
`2
`
`
`